Status:
UNKNOWN
PROSPECTIVE ANALYSIS BETWEEN AMIODARONE Versus LIDOCAINE IN SVT
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Arrhythmias Ventricular
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Introduction: Recent studies have suggested that other medications may be superior to amiodarone in controlling ventricular arrhythmias. However, a prospective and randomized comparison with lidocaine...
Eligibility Criteria
Inclusion
- Adult men and women\> 18 years old
- Presence of sustained ventricular tachycardia with HR\> 120 bpm
- Systolic blood pressure\> 90 mmHg
- No signs of poor peripheral perfusion
- Absence of dyspnea
- Absence of severe angina
- Signed consent form
Exclusion
- Pregnancy
- Hemodynamic instability
- Body mass index greater than 40 kg / m2
- Use of intravenous amiodarone or lidocaine in the last 24 hours
- Acute coronary syndrome
- Presence of tachycardia with irregular or supraventricular RR
- Contraindications to study drugs
Key Trial Info
Start Date :
August 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 2 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03299517
Start Date
August 2 2017
End Date
August 2 2022
Last Update
October 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto do Coração - HMFMUSP
São Paulo, São Paulo, Brazil, 05403000